We have demonstrated that gamma (Gamma) MSH peptides have dose-dependent natriuretic and hypertensive activity. The major source of circulating Gamma MSH, the pars intermedia, has been implicated in sodium metabolism. In addition, dopamine agonists, which inhibit pars intermedia secretion, have antihypertensive effects. These data suggest a possible role for the pars intermedia, specifically Gamma MSH, in renal and cardiovascular physiology. This proposal is to investigate the mechanism of Gamma MSH, induced hypertension, and to begin to discern the role of Gamma MSH and the pars intermedia in volume and cardiovascular regulation. Gamma MSH hypertension will be investigated by using chronic intra-arterial or intracerebroventricular infusions in rats. This will allow us to compare central vs. peripheral effects. Possible mechanisms for investigation include; sympathetic nervous system activation, direct vascular effects, resetting of baroreceptors, potentiation of endogenous vasoconstrictors, and secretion of adrenocorticoids. The physiological role of Gamma MSH and the pars intermedia will be examined in saline-expanded and DOC-salt hypertensive rats. These experiments will include; measurement of circulating Gamma MSH, inhibition of hypophyseal Gamma MSH secretion by dexamethasone and/or bromocryptine treatment, selective removal of the neurointermediate lobe, and injection of Gamma MSH antibodies. We will correlate these measurements or interventions to blood pressure and sodium excretion. The renal effects of bolus injections and infusions of Gamma MSH in rate will be examined by measuring renal blood flow, glomerular filtration rate, and fractional sodium excretion. Sympathetic nervous system contributions will be determined by selective pharmacological blockage of adrenergic receptors and the use of denervated kidneys. The successful implementation of this proposal could help define a previously unrecognized class of renal and cardiovascular system regulating hormones, and provide a possible role for the pars intermedia in mammalian physiology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033506-03
Application #
3345455
Study Section
(SRC)
Project Start
1984-09-30
Project End
1988-09-29
Budget Start
1986-09-30
Budget End
1988-09-29
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Gruber, K A; Callahan, M F; Eskridge-Sloop, S L (1992) Central administration of angiotensin II receptor antagonists and arterial pressure regulation: a note of caution. Life Sci 50:1497-502
Edwards, G L; Johnson, A K (1991) Enhanced drinking after excitotoxic lesions of the parabrachial nucleus in the rat. Am J Physiol 261:R1039-44
Gruber, K A; Eskridge-Sloop, S L; Eldridge, J C et al. (1989) ACTH-induced hypertension in rats: fact or artifact? Am J Physiol 256:R1308-12
Gruber, K A; Callahan, M F (1989) ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides. Am J Physiol 257:R681-94
Mitchell, L D; Callahan, M F; Wilkin, L D et al. (1989) Activation of supraoptic magnocellular neurons by gamma 2-melanocyte stimulating hormone (gamma 2-MSH). Brain Res 480:388-92
Gruber, K A; Eskridge-Sloop, S L; Callahan, M F (1988) Dehydration natriuresis in Dahl S rats: no evidence for renal excretory deficit. J Hypertens 6:333-6
Gruber, K A (1987) The natriuretic response to hydromineral imbalance. Hypertension 10:I48-51
Gruber, K; McRae-Degueurce, A; Wilkin, L D et al. (1987) Forebrain and brainstem afferents to the arcuate nucleus in the rat: potential pathways for the modulation of hypophyseal secretions. Neurosci Lett 75:1-5
Gruber, K A; Eskridge, S L; Callahan, M F (1987) Activation of the central vasopressin system: a potential factor in the etiology of hypertension. Klin Wochenschr 65 Suppl 8:82-6
Gruber, K A; Eskridge, S L (1986) Central vasopressin system mediation of acute pressor effect of gamma-MSH. Am J Physiol 251:E134-7

Showing the most recent 10 out of 11 publications